2023 Annual Meeting | C83 - Wake Up to Daytime Sleepiness: New and Emerging Concepts in the Diagnosis and Treatment of Hypersomnia Disorders

Date Monday 04/24/23

Time 08:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Nancy R. Foldvary-Schaefer, DO, FAAN

Topic(s) Sleep

Learning Objectives Participants should be able to identify the extensive burden of excessive daytime sleepiness and learn to differentiate hypersomnia disorders using the clinical history and evidence-based tools; discuss the data on sleep laboratory testing in narcolepsy, idiopathic hypersomnia, and other hypersomnia disorders and the pitfalls and limitations of the multiple sleep latency test in these populations; review the evidence for alerting medications for primary hypersomnia disorders and neurologic disorders featuring hypersomnia as a key component, and analyze the safety and efficacy of new and emerging therapies with unique mechanisms of action; and recognize the quality of life, functional and clinical impact of hypersomnia disorders to strengthen dialogues with patients, families, and caregivers.

This program is supported in part by an educational grant from Harmony Biosciences, LLC.

The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic, Audience Participation

Event Timeline
08:00 AM - 08:05 AM EST	Introduction	Introduction Nancy R. Foldvary-Schaefer, DO, FAAN
08:05 AM - 08:20 AM EST	Speaker	Evolution in Phenotyping Primary CNS Hypersomnias Yves Dauvilliers, MD, PhD
08:20 AM - 08:35 AM EST	Speaker	Diagnostic Testing: Beyond the MSLT Nancy R. Foldvary-Schaefer, DO, FAAN
08:35 AM - 08:50 AM EST	Speaker	New and Emerging Therapies for CNS Hypersomnias Michael J. Thorpy, MD
08:50 AM - 09:00 AM EST	Discussion	Panel Discussion Nancy R. Foldvary-Schaefer, DO, FAAN, Michael J. Thorpy, MD, Yves Dauvilliers, MD, PhD

Faculty Disclosures
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Michael J. Thorpy, MD	Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.